Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  192 results for ""Sodium-Glucose Transporter 2 Inhibitors""

Your Filters

Publisher : wiley
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Effect of Sodium Glucose Cotransporter-2 Inhibitors on Hemoglobin A1c Variability and Acute Kidney Injury: A Causal Mediation Analysis.

  • Authors : Wang T; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Ji D

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Aug; Vol. 33 (8), pp. e5876.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical Outcomes in Type 2 Diabetes Patients After Acute Myocardial Infarction: A Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs. Non-Users.

  • Authors : Lee HF; Division of Cardiology, Department of Internal Medicine, New Taipei City Municipal Tucheng Hospital, New Taipei City, Taiwan.; The Cardiovascular Department, Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Aug; Vol. 116 (2), pp. 426-434. Date of Electronic Publication: 2024 May 13.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial.

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/physiopathology ; Glucosides*/Glucosides*/Glucosides*/therapeutic use

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Aug; Vol. 26 (8), pp. 1727-1735. Date of Electronic Publication: 2024 May 23.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Mechanistic Modeling of Empagliflozin: Predicting Pharmacokinetics, Urinary Glucose Excretion, and Investigating Compensatory Role of SGLT1 in Renal Glucose Reabsorption.

  • Authors : Ping X; Basic Teaching Department, Baoding Technical College of Electric Power, Baoding, Hebei, China.; Wang G

Subjects: Glucosides*/Glucosides*/Glucosides*/pharmacokinetics ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/pharmacokinetics ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/urine

  • Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Jun; Vol. 64 (6), pp. 672-684. Date of Electronic Publication: 2024 Feb 16.Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin.

  • Authors : Lapuerta P; Youngene Therapeutics Co., Ltd., Zhangjiang Hi-Tech Park, Shanghai, China.; Urbina S

Subjects: Cross-Over Studies* ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/blood

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1383-1390. Date of Electronic Publication: 2024 Mar 08.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Sodium-glucose cotransporter 2 inhibitors in acute and chronic coronary syndrome with and without heart failure.

  • Authors : Cisneros-Barroso E; Internal Medicine Department, Hospital Universitari Son Llàtzer, Palma, Spain.; Facultad de Medicina, Universitat de les Illes Balears (UIB), Palma, Spain.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Jul; Vol. 26 (7), pp. 1606-1607. Date of Electronic Publication: 2024 May 29.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of dapagliflozin in patients with diabetes and heart failure with mildly reduced or preserved ejection fraction according to background glucose-lowering therapy: A pre-specified analysis of the DELIVER trial.

  • Authors : Lassen MCH; Department of Medicine, Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.

Subjects: Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 Jul; Vol. 26 (7), pp. 1539-1548. Date of Electronic Publication: 2024 May 15.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors.

  • Authors : Tan GSQ; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia.; Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Hospitalization*/Hospitalization*/Hospitalization*/statistics & numerical data ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1304-1315. Date of Electronic Publication: 2024 Feb 09.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Dapagliflozin Reduces Urinary Kidney Injury Biomarkers in Chronic Kidney Disease Irrespective of Albuminuria Level.

  • Authors : Cho J; Division of Nephrology, Soonchunhyang University Seoul Hospital, Seoul, Korea.; Doo SW

Subjects: Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use ; Albuminuria*/Albuminuria*/Albuminuria*/urine ; Albuminuria*/Albuminuria*/Albuminuria*/drug therapy

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1441-1449. Date of Electronic Publication: 2024 Mar 07.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

From Plan to Pivot: How Model-Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH Trials.

  • Authors : Mercier AK; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Ueckert S

Subjects: Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/pharmacokinetics ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/administration & dosage ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/pharmacology

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Sep; Vol. 116 (3), pp. 653-664. Date of Electronic Publication: 2024 Jul 03.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
  • 1-10 of  192 results for ""Sodium-Glucose Transporter 2 Inhibitors""